| Bladder Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived80 of 80show fewer |
|---|
| → investigated in trials for | Gemcitabinesmall molecule 41 trials (26 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 30 trials (20 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 26 trials (17 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 17 trials (12 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 16 trials (11 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 12 trials (11 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nadofaragene Firadenovecgene therapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal_antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bacillus Calmette-Guerin BCG 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumab/Tremelimumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal_antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |